We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Abcam Signs License Agreement with Pfizer

News   Jun 12, 2013

 
Abcam Signs License Agreement with Pfizer
 
 
Advertisement
 

RELATED ARTICLES

Enzyme Has Newly-Discovered Potential To Clear Huntington's Protein

News

Scientists have identified an enzyme that could play a central role in developing a new route of treatment for Huntington's disease.

READ MORE

Discovering the Strategies Tumor Cells Use To Evade Immune Attack

News

A new study has uncovered the strategies tumor cells use to evade immune system attack. The method developed for this work contributes to a better understanding of the "arms race" between immune defense and disease.

READ MORE

HDAC6 Halts the Spread of Triple-Negative Breast Cancer

News

The genetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE